HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Rainer G. Leyh Axel Haverich Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Leyh, R. G. Articles by Haverich, A. Search for Related Content PubMed PubMed Citation Articles by Leyh, R. G. Articles by Haverich, A. Related Collections Lung - cancer

Eur J Cardiothorac Surg 2002;21:577-579
© 2002 Elsevier Science NL

Case report

Anticoagulation for prosthetic heart valves during pregnancy: is low-molecular-weight heparin an alternative?

Division of Thoracic and Cardiovascular Surgery, Hanover Medical School, Carl Neuberg Strasse 1, 30623 Hannover, Germany

Received 25 May 2001; received in revised form 27 November 2001; accepted 12 December 2001.

* Corresponding author. Tel.: +49-532-6581; fax: +49-532-5404
e-mail: leyh{at}thg.mh-hannover.de

We report on the treatment failure of low molecular weight heparin (LMWH) for anticoagulation in a pregnant woman that underwent artificial mitral valve replacement 10 years prior to her pregnancy. Until she became pregnant warfarin was administered for anticoagulation, but due to the often mentioned increased risk for warfarin-induced maternal and fetal complications, at gestational week 5 the anticoagulation regimen was switched to subcutaneous application of low molecular weight heparin. At gestational week 24 our patient developed acute life-threatening pulmonary edema and hemodynamic instability due to acute mitral valve thrombosis and underwent emergency valve re-replacement with a biological porcine valve. She recovered uneventfully and gave birth to a healthy child at gestational week 35. In addition to our case presentation we review the sparse evidence in the literature regarding anticoagulation in pregnant women with mechanical heart valves and discuss the rational of different anticoagulation regimens with regards to maternal and fetal outcome. Special consideration is directed towards LMWH administration as an alternative to oral anticoagulation during pregnancy in women with mechanical heart valves.

Key Words: Pregnancy • Anticoagulation • Prosthetic heart valves • Low molecular weight heparin

This article has been cited by other articles:

				A. Gerhardt, R. E. Scharf, and R. B. Zotz Successful Use of Danaparoid in Two Pregnant Women With Heart Valve Prosthesis and Heparin-Induced Thrombocytopenia Type II (HIT) Clinical and Applied Thrombosis/Hemostasis, August 1, 2009; 15(4): 461 - 464. [Abstract] [PDF]

				S. M. Bates, I. A. Greer, I. Pabinger, S. Sofaer, and J. Hirsh Venous Thromboembolism, Thrombophilia, Antithrombotic Therapy, and Pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest, June 1, 2008; 133(6_suppl): 844S - 886S. [Abstract] [Full Text] [PDF]

				A. J Khamooshi, F. Kashfi, S. Hoseini, M. B Tabatabaei, H. Javadpour, and F. Noohi Anticoagulation for Prosthetic Heart Valves in Pregnancy. Is There an Answer? Asian Cardiovasc Thorac Ann, December 1, 2007; 15(6): 493 - 496. [Abstract] [Full Text] [PDF]

				I. A. Greer and C. Nelson-Piercy Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy Blood, July 15, 2005; 106(2): 401 - 407. [Abstract] [Full Text] [PDF]

				M. A Geelani, S. Singh, A. Verma, A. Nagesh, V. Betigeri, and M. Nigam Anticoagulation in Patients with Mechanical Valves During Pregnancy Asian Cardiovasc Thorac Ann, March 1, 2005; 13(1): 30 - 33. [Abstract] [Full Text] [PDF]

				S. M. Bates, I. A. Greer, J. Hirsh, and J. S. Ginsberg Use of Antithrombotic Agents During Pregnancy: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy Chest, September 1, 2004; 126(3_suppl): 627S - 644S. [Abstract] [Full Text] [PDF]

				N. Vitale, M. De Feo, and M. Cotrufo Anticoagulation for prosthetic heart valves during pregnancy: the importance of warfarin daily dose Eur. J. Cardiothorac. Surg., October 1, 2002; 22(4): 656 - 656. [Full Text] [PDF]

				R. G. Leyh, S. Fischer, A. Ruhparwar, and A. Haverich Reply to Vitale et al. Eur. J. Cardiothorac. Surg., October 1, 2002; 22(4): 657 - 657. [Full Text] [PDF]